- 3.9Impact Factor
- 6.8CiteScore
- 18 daysTime to First Decision
Special Issues
Sustainability publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Advances in Chronic Obstructive Pulmonary Disease (COPD)
Deadline: 30 April 2026
New Advances in Cardiovascular Drugs: In Memory of Professor Akira Endo (2nd Edition)
Deadline: 30 April 2026
Cellular and Molecular Mechanisms in Gastrointestinal Tract Disease: 2nd Edition
Deadline: 29 April 2026
The Role of Cytokines in Health and Disease: 3rd Edition
Deadline: 20 April 2026
New Insights in Gastric, Colorectal, and Pancreatic Cancer
Deadline: 31 March 2026
Recent Advances in Endocrine Disease and Atherosclerosis
Deadline: 31 March 2026
Renal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches (3rd Edition)
Deadline: 31 March 2026
Clinical Electrophysiology for Precision Diagnosis for Cardiology and Central Nervous System Diseases
Deadline: 31 March 2026
Advances in Immune Cell Biology: Insights from Molecular Perspectives
Deadline: 31 March 2026
Noncoding RNAs (ncRNAs): The Role in Gene Regulation and Human Diseases
Deadline: 31 March 2026
Hepato-Pancreato-Biliary Cancers: Pathogenesis, Comorbidities and Therapy Updated
Deadline: 31 March 2026
Cholinergic System Neurodegeneration: Novel Pharmacotherapy
Deadline: 31 March 2026
of 148

